Loading...
Market
When will Johnson & Johnson launch the first product using V-Wave's Ventura® technology by December 31, 2025?
2
Resolution / Starting Odds
Q1 2025 • 25%
Q2 2025 • 25%
Q3 2025 • 25%
Q4 2025 • 25%
Official product launch announcement from Johnson & Johnson
Story
Johnson & Johnson to Acquire V-Wave for Up to $1.7 Billion
Aug 20, 2024, 11:53 AM
Johnson & Johnson has announced its agreement to acquire V-Wave, a privately-held company specializing in innovative treatment options for heart failure. The acquisition involves an upfront payment of $600 million, with the total deal potentially reaching up to $1.1 billion, contingent on achieving specific milestones. Some reports suggest the deal could be worth up to $1.7 billion. This strategic move aims to enhance Johnson & Johnson's MedTech cardiovascular portfolio, particularly through V-Wave's innovative Ventura® technology.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Johnson & Johnson • 25%
Merck • 25%
AstraZeneca • 25%
Other • 25%
1 • 25%
2-3 • 25%
4-5 • 25%
More than 5 • 25%
Yes • 50%
No • 50%
Below $7.5 billion • 25%
$7.5 billion to $8 billion • 25%
$8 billion to $8.5 billion • 25%
Above $8.5 billion • 25%